Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Cystadane (Betaine Anhydrous) Covered by Aetna CVS Health in North Carolina: Complete PA Guide with Appeal Scripts

Answer Box: Getting Cystadane Covered by Aetna CVS Health in North Carolina Quick Path to Coverage: Cystadane (betaine anhydrous) typically requires prior authorization from Aetna CVS Health. Your doctor must submit genetic/biochemical confirmation of homocystinuria, document vitamin co-therapy plans, and provide dosing rationale. If denied, North Carolina offers strong

How to Get Alecensa (Alectinib) Covered by Aetna CVS Health in New Jersey: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Alecensa Covered by Aetna CVS Health in New Jersey Yes, Aetna covers Alecensa (alectinib) for ALK-positive NSCLC with prior authorization. The fastest path to approval requires three essentials: confirmed ALK-positive test results, a comprehensive medical necessity letter from your oncologist, and electronic submission through CVS Caremark'

Coding That Helps Get Jaypirca (Pirtobrutinib) Approved by Aetna (CVS Health) in Washington: ICD-10, HCPCS J-Code, and NDC Guide

Answer Box: Getting Jaypirca (Pirtobrutinib) Approved by Aetna (CVS Health) in Washington Key codes needed: ICD-10 C83.1 (mantle cell lymphoma) or C91.1/C83.0 (CLL/SLL) with relapse status; HCPCS J9399; NDC varies by strength. Fastest approval path: Submit prior authorization through CVS Caremark with complete documentation of

How to Get Helixate (Antihemophilic Factor VIII) Covered by Aetna CVS Health in Georgia: Prior Authorization, Appeals & External Review

Quick Answer: Getting Helixate Covered by Aetna CVS Health in Georgia Important Update: Helixate has been discontinued in the United States. If you previously used Helixate, your hematologist must transition you to an available alternative recombinant Factor VIII product covered by Aetna CVS Health, such as Kovaltry, Advate, or Jivi.

Myths vs. Facts: Getting Oxbryta (Voxelotor) Covered by Aetna in Illinois - What Patients Need to Know

Answer Box: Oxbryta Coverage Reality in Illinois Critical Update: Oxbryta (voxelotor) was voluntarily withdrawn from the U.S. market by Pfizer in September 2024 due to safety concerns. Claims are now denied due to loss of FDA approval. Illinois patients with sickle cell disease should work with their healthcare providers

How to Get Naglazyme (galsulfase) Covered by Aetna (CVS Health) in Illinois: Prior Authorization Guide, Appeal Scripts & Timeline

Answer Box: Getting Naglazyme (galsulfase) Covered by Aetna (CVS Health) in Illinois Naglazyme requires prior authorization from Aetna CVS Health. Your fastest path to approval: (1) Have your metabolic specialist submit enzyme assay or genetic testing confirming MPS VI diagnosis, (2) Request a medical necessity letter addressing Aetna's

How to Get Upstaza (Eladocagene Exuparvovec) Covered by Aetna CVS Health in Virginia: Complete Coverage Guide

Answer Box: Getting Upstaza Covered by Aetna CVS Health in Virginia Fastest path to approval: Upstaza (eladocagene exuparvovec), now FDA-approved as Kebilidi in the US, requires prior authorization through Aetna's Gene-Based, Cellular, and Other Innovative Therapies (GCIT) network. First step: contact your neurologist to confirm AADC deficiency diagnosis

How to Get Ferriprox (Deferiprone) Covered by Aetna CVS Health in California: Prior Authorization Appeals Guide 2025

Answer Box: Getting Ferriprox Covered by Aetna CVS Health in California Fastest path to approval: Submit prior authorization with documented ferritin >1,000 mcg/L, ANC monitoring plan, and diagnosis of transfusional iron overload from thalassemia or sickle cell disease. If denied, file internal appeal within 60 days, then

Renewing Prolastin-C (Alpha1-Proteinase Inhibitor) Approval with Aetna CVS Health in Washington: Timeline, Documentation & Appeal Guide

Answer Box: Renewing Prolastin-C Coverage with Aetna CVS Health Start your renewal 90 days early. Aetna typically approves Prolastin-C for 3-6 months initially, then 12-month renewals. You'll need updated AAT levels, FEV1 results, and proof of clinical benefit. Submit 60 days before expiration through CVS Caremark or your

How Long Does It Take to Get Vanflyta (Quizartinib) Approved by Aetna (CVS Health) in New York? Complete Timeline & Appeals Guide

Answer Box: Getting Vanflyta Covered by Aetna (CVS Health) in New York Standard approval timeline: 30-45 days for prior authorization, with expedited review available in 72 hours for urgent cancer treatment. Aetna requires FLT3-ITD mutation testing, baseline EKG showing QTc ≤450ms, and AML diagnosis confirmation. If denied, New York residents